Researchers from New England Biolabs (NEB®) and Yale University describe the first fully synthetic bacteriophage engineering ...
Researchers have developed EVE-Vax, an AI tool that forecasts viral mutations and designs test proteins to guide next-generation vaccines. The breakthrough could allow scientists to build vaccines ...
As the industry moves toward continuous bioprocessing, more effective ways are being developed to validate viral clearance. Researchers at Asahi Kasei Bioprocess America have developed a small-scale ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results